Physician profile
Amy Tefft
NPI 1063943074
$1,181.44
in general payments reported to CMS, 2019-2025
16 companies · $121 in 2025
The $121 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $22.64 · 2022: $203 · 2023: $191 · 2024: $644 · 2025: $121.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $558 · Food and Beverage: $397.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $557.95 |
| Food and Beverage | $397.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zavation Medical Products, LLC | $557.95 | 2024 | |
| Davol INC. | $215.98 | 2022-2025 | Arista, Phasix Mesh |
| Intuitive Surgical, INC. | $84.80 | 2023 | Da Vinci Surgical System |
| Molli Surgical (US) INC | $69.43 | 2022-2023 | |
| W. L. Gore & Associates, INC. | $55.23 | 2021-2024 | Gore Enform Preperitoneal Biomaterial |
| Vertex Pharmaceuticals Incorporated | $33.79 | 2024-2025 | |
| Silk Road Medical, INC. | $24.31 | 2022 | |
| Conmed Corporation | $21.90 | 2024 | Airseal |
| Microline Surgical INC | $16.78 | 2023 | |
| Heron Therapeutics, INC. | $16.47 | 2023 | Aponvie |
| Convatec INC. | $15.00 | 2025 | |
| Tela Bio, INC. | $14.13 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Merit Medical Systems INC | $14.05 | 2022 | |
| Polynovo North America LLC | $13.95 | 2025 | Novosorb Btm |
| Pacira Pharmaceuticals Incorporated | $13.86 | 2024 | Exparel |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solventum Corporation | $13.81 | 2025 | Prevena, V.A.C.Ulta, V.A.C. Veraflo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Tefft listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.